Log in
Enquire now
‌

US Patent 10900027 Recombinant prothrombin analogues and uses thereof

Patent 10900027 was granted and assigned to Cleveland State University on January, 2021 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributors

Contents

Is a
Patent
Patent

Patent attributes

Patent Applicant
Cleveland State University
Cleveland State University
Current Assignee
Cleveland State University
Cleveland State University
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
Patent Number
10900027
Patent Inventor Names
Joseph Wiencek0
Michael Kalafatis0
Date of Patent
January 26, 2021
Patent Application Number
15766901
Date Filed
October 7, 2016
Patent Citations Received
‌
US Patent 11959110 Recombinant prothrombin analogues and uses thereof
0
Patent Primary Examiner
‌
Maury A Audet
Patent abstract

During the process of coagulation, prothrombin is activated to α-thrombin by prothrombinase. Key residues in the structure of prothrombin allow for modulation of the activation of prothrombin. In certain embodiments, a recombinant prothrombin with at least one point mutation or deletion is provided.

Timeline

No Timeline data yet.

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more entities like US Patent 10900027 Recombinant prothrombin analogues and uses thereof

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us